“Breakthrough Research Unveils New Hope for Treating Metabolic Dysfunction-Associated Liver Disease”
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as “non-alcoholic fatty liver disease,” impacts roughly 25% of the world’s […]